Journal of the National Cancer Institute Advance Access originally published online on August 28, 2007
JNCI Journal of the National Cancer Institute 2007 99(17):1344-1345; doi:10.1093/jnci/djm103
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press.
CORRESPONDENCE |
Re: Ovarian Ablation or Suppression in Premenopausal Early Breast Cancer: Results from the International Adjuvant Breast Cancer Ovarian Ablation or Suppression Randomized Trial
Affiliation of authors: Division of Medical Oncology A, Regina Elena Cancer Institute, Rome, Italy
Correspondence to: Gianluigi Ferretti, MD, PhD, Division of Medical Oncology A, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy (e-mail: gia.fer@flashnet.it).
| The first 10% of the full text of this article appears below. |
According to the Adjuvant Breast Cancer Trials Collaborative Group (ABCTCG) (1), women were defined as pre- or perimenopausal if their last menstrual period had occurred within the 12 months before breast diagnostic surgery. Dates for the last menstrual period may be inaccurate due to poor patient recollection, miscommunication, or abnormal bleeding.
Article about this Correspondence
Related Article in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 516-525.
J Natl Cancer Inst 2007 99: 516-525.